Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (scFv-Fc)  (BSCFV-132)

Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD89 specificity or anti-EGFR specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.

Datasheet